Skip to main content
Figure 3 | Biological Procedures Online

Figure 3

From: Streptozotocin, Type I Diabetes Severity and Bone

Figure 3

Body, muscle and fat pad mass decreases with both low and high dose STZ treatment. Body, muscle (tibialis anterior), liver, and fat pad (subcutaneous femoral fat) weights were measured at 19 dpi for control (white bar), 40 mg/kg STZ (low dose, gray bar), or 60 mg/kg STZ mice (high dose, black bar). Values represent the average ± SE. n > 3 per condition. *p < 0.05 compared to control; Δ p < 0.05 compared to 40-mg/kg STZ dose.

Back to article page